![](https://blogs.uml.edu/m2d2/wp-content/uploads/sites/46/2019/03/dynocardia-logo.png)
![](https://blogs.uml.edu/m2d2/wp-content/uploads/sites/46/2019/03/Mahan.jpg)
Dynocardia is 1 of 19 finalists chosen to pitch at the $200K Challenge Pitch-Off last Wednesday. Dynocardia’s ViTrack™ is the first-of-its-kind, standalone, cuff-less, wearable device for continuous non-invasive blood pressure monitoring.
Mohan Thanikachalam, CEO of Dynocardia, offers us an exclusive inside look behind the development of the ViTrackTM!
Read more